Camlin Fine Sciences (BOM:532834) Debt-to-Equity : N/A (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Camlin Fine Sciences Debt-to-Equity?

Camlin Fine Sciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0 Mil. Camlin Fine Sciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0 Mil. Camlin Fine Sciences's Total Stockholders Equity for the quarter that ended in Dec. 2024 was ₹0 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Camlin Fine Sciences's Debt-to-Equity or its related term are showing as below:

BOM:532834' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.73 Med: 1.02 Max: 1.87
Current: 1.11

During the past 13 years, the highest Debt-to-Equity Ratio of Camlin Fine Sciences was 1.87. The lowest was 0.73. And the median was 1.02.

BOM:532834's Debt-to-Equity is ranked worse than
86.59% of 1394 companies
in the Chemicals industry
Industry Median: 0.37 vs BOM:532834: 1.11

Camlin Fine Sciences Debt-to-Equity Historical Data

The historical data trend for Camlin Fine Sciences's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camlin Fine Sciences Debt-to-Equity Chart

Camlin Fine Sciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Equity

Get a 7-Day Free Trial

1.34

0.86

0.98

0.79

Camlin Fine Sciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Equity	Get a 7-Day Free Trial															N/A	0.79	N/A	1.11	N/A

Competitive Comparison of Camlin Fine Sciences's Debt-to-Equity

For the Specialty Chemicals subindustry, Camlin Fine Sciences's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Camlin Fine Sciences's Debt-to-Equity Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Camlin Fine Sciences's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Camlin Fine Sciences's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Camlin Fine Sciences Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Camlin Fine Sciences's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3331.53	+	3498.784)	/	8647.508
	=	0.79

Camlin Fine Sciences's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	0
	=	N/A

Camlin Fine Sciences (BOM:532834) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Camlin Fine Sciences Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Camlin Fine Sciences's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Camlin Fine Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Camlin Fine Sciences Ltd (BOM:532834) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

CAMLINFINE:India

Address

CST Road, Kalina, Floor 2 to 5, In GS Point, Santacruz East, Mumbai, MH, IND, 400 098

Website

https://www.camlinfs.com

Camlin Fine Sciences Ltd is engaged in research, development, manufacturing, commercializing, and marketing of specialty chemicals and blends. These chemicals are used in food, feed, animal and pet nutrition and industrial products. The Company has only one reportable segment, namely, Speciality Chemicals. The company's product portfolio consists of Shelf life solutions, Aroma ingredients, Performance chemicals and Health & Wellness. Shelf life extension solutions include antioxidant solutions which are used to increase the shelf life of oils and. Aroma vertical includes a production of Vanillin and Ethyl Vanillin. Performance Chemicals consist of Guaiacol, Veratrole, TBC, and MEHQ and are used in sectors such as food flavoring, pharmaceuticals intermediate fragrance industry.

Camlin Fine Sciences Headlines

No Headlines